Anti-tumor compounds

Details Anti-tumor compounds Anti-tumor compounds

2005-12-15

2008-11-25

Wilson, James O. (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S276400, C546S276700

Reexamination Certificate

active

07456289

ABSTRACT:
Compounds of the following formula:wherein A, D, Q, T, U, V, W, X, Y, Z, R1, andare as defined herein. This invention also relates to a method of inhibiting tubulin polymerization, or treating cancer or an angiogenesis-related disorder with one of these compounds.

REFERENCES:
patent: 3557142 (1971-01-01), Bell
patent: 5013837 (1991-05-01), Ward et al.
patent: 5468898 (1995-11-01), Huang et al.
patent: 5486525 (1996-01-01), Summers et al.
patent: 5753664 (1998-05-01), Aono et al.
patent: 5760040 (1998-06-01), Yoshida et al.
patent: 6013648 (2000-01-01), Rinaldi et al.
patent: 6162930 (2000-12-01), Pinney et al.
patent: 6350777 (2002-02-01), Pinney et al.
patent: 6515141 (2003-02-01), Goto et al.
patent: 6787651 (2004-09-01), Stolle et al.
patent: 6933316 (2005-08-01), Hsich et al.
patent: 2004/0167030 (2004-08-01), Bernotas et al.
patent: 2004/0259936 (2004-12-01), Nagarkatti et al.
patent: 2006/0030583 (2006-02-01), Arnold et al.
patent: 2007/0049615 (2007-03-01), Ibrahim et al.
patent: 199 47 863 (2001-04-01), None
patent: WO 92/06088 (1992-04-01), None
patent: WO93/13099 (1993-07-01), None
patent: WO 95/14003 (1995-05-01), None
patent: WO 98/08818 (1998-03-01), None
patent: WO 00/48606 (2000-08-01), None
patent: WO 00/51983 (2000-09-01), None
patent: WO00/53582 (2000-09-01), None
patent: WO 01/09103 (2001-02-01), None
patent: WO 01/19794 (2001-03-01), None
patent: WO 01/19794 (2001-03-01), None
patent: WO 01/28557 (2001-04-01), None
patent: WO 01/68654 (2001-09-01), None
patent: WO02/36561 (2002-05-01), None
patent: WO 02/36561 (2002-05-01), None
patent: WO02/36597 (2002-05-01), None
patent: WO 02/50007 (2002-06-01), None
patent: WO 02/060872 (2002-08-01), None
patent: WO03/101990 (2003-12-01), None
patent: WO2004/009600 (2004-01-01), None
patent: WO2006/015123 (2006-02-01), None
Angiogenesis [internet May 1, 2007] http:// cancer.gov/cancertopics/understandingcancer/angiogenesis/Slide26>.
Angiognesis Inhibitors in the Treatment of Cancer, [internet May 1, 2007] <http://www.cancer.gov/cancertopis/factsheet/Therapy/angiogenesis-inhibitors/print?page=&keyword=)>.
Goloub et al., Oct. 15, 1999, Science, 286: 531-537.
Goto et al. , 2000, STN International CAPLUS database, Columbus, Ohio, Accession No. 2001:167965.
Griffioen et al., Pharmacological Reviews 52(2):237-268 2000.
Homma et al., Journal of National Cancer Institute, 89(11):803-807 Jun. 1997.
Hortobagyi, G., Oct. 1, 1998, N. Eng. J. Med., 339:974-984.
Kimmel et al., J. Neurosurg. 66:161-171 1987.
Kuo et al., “BPR0L075, A Novel Synthetic Indole Compound with Antimitotic Activity in Human Cancer Cells, Exerts Effective Antitumoral Activityin Vivo,” Cancer Research, 64:4621-4628 (2004).
Liou et al., “Concise Synthesis and Structure- Activity Relationships of Combretastatin A-4 Ananlgues, 1-Aroylindoles and 3-Aroylindoles, as Novel Classes of Potent Antitubulin Agents,” J. Med. Chem. 47:4247-4257 (2004).
Minakata et al., “Functionalization of 1H-Pyrrolo[2,3-b]Pyridine,”The Chemical Society of Japan, vol. 65 No. 11, pp. 2992-2997, (1992).
Powell et al., “Further Examples of Preferred Transition State Geometries in the Oxidative Cyclisation of Indole and Isoquinoline Derivatives,” Tetrahedron Letters, vol. 22, pp. 4751-4754, 1981.
Samson et al., Chemotherapy Sensitivity and Resistance Assays; A Systematic Review, Sep. 1, 2004, J. Clinical Oncology 22(11): 3618-3630.
Song et al., “Isomerism of Bis(7-azaindolyl)Methane,”Organic Letters, vol. 4, No. 23, pp. 4049-4052, (2002).
Yakhontov et al., “Derivatives of 7-Azaindole XV Electrophilic Substitution in 4-Methyl-7-Azaindole and Its Derivatives,” (UDC 547.836.3) S. Ordzhonikidze All-Union Scientific Research Institute for Chemical Pharmaceutics, 1(11):2032-2040 (1965) (Original Article Submitted Jul. 20, 1964).
Yakhontov et al., “Derivatives of 7-Azaindole. XV. Electrophilic substation of 4-methyl-7-azaindole and its Derivatives.”Zhurnal Obshchei Khimii, vol. 1 No. 11, pp. 2032-2040, (1965).
Yeung et al., “Friedel-Crafts Acylation of Indoles in Acidic Imidazolium Chloroaluminate Ionic Liquid at Room Temperature,”Tetrahedron Letters, Vol. No. 43, pp. 5793-5795, (2002).

Affiliated with

Also associated with

Rating

Anti-tumor compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-tumor compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-tumor compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4037434